Palliative care 2016

Retrospec+ve cohorts

Author/year

# pts. LNmet/ total

Primary Fract x dose

Local control 2-­‐years

Survival 2-­‐years

Severe morbidity

Mixed (lung; n=20)

30 16 pall.

4 x 4Gy 10 x 5Gy

55% (1-­‐year)

44% (1-­‐year)

Chawla 2009

No

Holy 2011 Adrenal metastases: Local control rates 55-­‐90 % 13 (18) NSCLC 5 x 4-­‐8Gy 77% 50% Grade 3 (n=2)

Mixed (lung; n=24)

Casamassima 2012

48

3 x 12Gy

90%

40%

No

Made with